Your browser doesn't support javascript.
loading
Direct Endothelial Nitric Oxide Synthase Activation Provides Atheroprotection in Diabetes-Accelerated Atherosclerosis.
Sharma, Arpeeta; Sellers, Stephanie; Stefanovic, Nada; Leung, Cleo; Tan, Sih Min; Huet, Olivier; Granville, David J; Cooper, Mark E; de Haan, Judy B; Bernatchez, Pascal.
Afiliação
  • Sharma A; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada Baker IDI Heart and Diabetes Institute, Diabetic
  • Sellers S; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
  • Stefanovic N; Baker IDI Heart and Diabetes Institute, Diabetic Complications Division, Melbourne, Victoria, Australia.
  • Leung C; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
  • Tan SM; Baker IDI Heart and Diabetes Institute, Diabetic Complications Division, Melbourne, Victoria, Australia.
  • Huet O; Baker IDI Heart and Diabetes Institute, Diabetic Complications Division, Melbourne, Victoria, Australia.
  • Granville DJ; Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Cooper ME; Baker IDI Heart and Diabetes Institute, Diabetic Complications Division, Melbourne, Victoria, Australia Department of Immunology, Monash University, Melbourne, Victoria, Australia.
  • de Haan JB; Baker IDI Heart and Diabetes Institute, Diabetic Complications Division, Melbourne, Victoria, Australia Department of Immunology, Monash University, Melbourne, Victoria, Australia judy.dehaan@bakeridi.edu.au pascal.bernatchez@ubc.ca.
  • Bernatchez P; Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada judy.dehaan@bakeridi.edu.au pascal.bernatchez@ub
Diabetes ; 64(11): 3937-50, 2015 Nov.
Article em En | MEDLINE | ID: mdl-26116699

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Endotélio Vascular / Células Endoteliais / Diabetes Mellitus Experimental / Angiopatias Diabéticas / Aterosclerose / Óxido Nítrico Sintase Tipo III Limite: Animals / Humans / Male Idioma: En Revista: Diabetes Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Endotélio Vascular / Células Endoteliais / Diabetes Mellitus Experimental / Angiopatias Diabéticas / Aterosclerose / Óxido Nítrico Sintase Tipo III Limite: Animals / Humans / Male Idioma: En Revista: Diabetes Ano de publicação: 2015 Tipo de documento: Article